S. 5237: Stop Superbugs Act
This bill would require the National Institute of Allergy and Infectious Diseases (NIAID) to award a competitive grant to the Antibiotic Resistance Leadership Group.
What the grant would be for
The grant would support a clinical research network focused on antibiotic resistance, sometimes called “superbugs.” The goal is to help researchers study how bacteria become resistant to antibiotics and how to improve treatment and testing.
Specific activities the network would support
Faster enrollment in clinical trials: helping recruit people into studies more quickly.
Community-based outreach: finding and informing potential trial participants in community settings, not just hospitals or academic centers.
Combined testing and treatment research: studying how diagnostic tools and drug treatments can be used together in trials.
Patient-reported outcomes: collecting information from patients about their symptoms, experiences, and results during studies.
Funding
The bill authorizes whatever funds are needed to carry out this grant program. It does not set a specific dollar amount in the text provided.
Relevant Companies
None found
This is an AI-generated summary of the bill text. There may be mistakes.
Sponsors
2 bill sponsors
Actions
2 actions
| Date | Action |
|---|---|
| Aug. 04, 2026 | Introduced in Senate |
| Aug. 04, 2026 | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.
Potentially Relevant Congressional Stock Trades
No relevant congressional stock trades found.